Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of liquid vs lyophilized trivalent Group B Streptococcus vaccine in healthy non-pregnant women
2013-003111-22Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2014
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of group b streptococcus trivalent vaccine in Streptococcus agalactiae infection (GBS) and Streptococcus agalactiae sepsis (2 arms), sponsored by GSK. Started Oct 2014; status: completed.
02
Drugs
group b streptococcus trivalent vaccine
03
Conditions
Streptococcus agalactiae infection (GBS)Streptococcus agalactiae sepsis
Beyond the preview
Go deeper on 2013-003111-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003111-22.